Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma
Background: Lung adenocarcinoma (LUAD) is the most common subtype of non-small cell lung cancer. Fatty acid metabolism takes part in malignancy progression. However, the roles fatty acid metabolism plays in LUAD are still unclear.Methods: The transcriptomic and clinical data of LUAD patients from Th...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-07-01
|
| Series: | Frontiers in Genetics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.905508/full |
| _version_ | 1811292480135495680 |
|---|---|
| author | Suyu Wang Suyu Wang Aona Chen Wanli Zhu Di Feng Juan Wei Quanfu Li Xuan Shi Xin Lv Meiyun Liu |
| author_facet | Suyu Wang Suyu Wang Aona Chen Wanli Zhu Di Feng Juan Wei Quanfu Li Xuan Shi Xin Lv Meiyun Liu |
| author_sort | Suyu Wang |
| collection | DOAJ |
| description | Background: Lung adenocarcinoma (LUAD) is the most common subtype of non-small cell lung cancer. Fatty acid metabolism takes part in malignancy progression. However, the roles fatty acid metabolism plays in LUAD are still unclear.Methods: The transcriptomic and clinical data of LUAD patients from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were extracted. ssGSEA, WGCNA, univariable Cox regression, and LASSO Cox regression analyses were performed to identify the fatty acid metabolism-related genes which influenced the overall survival (OS) and build a fatty acid-related risk score (FARS) model. A nomogram was established based on the FARS and other clinicopathological features, and ROC and calibration plots were used to validate the prediction accuracy. The tumor microenvironment (TME) of patients with high and low FARS was compared.Results: A total of 38 genes were identified to be independently related to the survival outcome and put into a FARS model. High FARS patients exhibited significantly worse OS. The nomogram included the FARS and pathological stage, and the AUC of the nomogram predicting 1-, 2-, 3-, 4-, and 5-year OS was 0.789, 0.807, 0.798, 0.809, and 0.753, respectively. Calibration plots also indicated good accuracy. Moreover, the samples of the high FARS had higher expression of PDL1.Conclusion: We constructed a FARS model which could accurately predict the survival outcome of the LUAD patients. The genes of the FARS are related to the tumor microenvironment and patients with high FARS can potentially benefit more from anti-PD1/PDL1 immunotherapy. In addition, the mechanisms of the genes in the FARS affecting prognosis are worthy of further research to develop new gene-targeted drugs. |
| first_indexed | 2024-04-13T04:45:55Z |
| format | Article |
| id | doaj.art-6172fe725c0b4820bd50d403ef4321bc |
| institution | Directory Open Access Journal |
| issn | 1664-8021 |
| language | English |
| last_indexed | 2024-04-13T04:45:55Z |
| publishDate | 2022-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Genetics |
| spelling | doaj.art-6172fe725c0b4820bd50d403ef4321bc2022-12-22T03:01:51ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-07-011310.3389/fgene.2022.905508905508Characterization of Fatty Acid Metabolism in Lung AdenocarcinomaSuyu Wang0Suyu Wang1Aona Chen2Wanli Zhu3Di Feng4Juan Wei5Quanfu Li6Xuan Shi7Xin Lv8Meiyun Liu9Department of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Cardiothoracic Surgery, Changzheng Hospital, Naval Medical University, Shanghai, ChinaDepartment of General Surgery, Changzheng Hospital, Naval Medical University, Shanghai, ChinaDepartment of General Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Anesthesiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, ChinaBackground: Lung adenocarcinoma (LUAD) is the most common subtype of non-small cell lung cancer. Fatty acid metabolism takes part in malignancy progression. However, the roles fatty acid metabolism plays in LUAD are still unclear.Methods: The transcriptomic and clinical data of LUAD patients from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were extracted. ssGSEA, WGCNA, univariable Cox regression, and LASSO Cox regression analyses were performed to identify the fatty acid metabolism-related genes which influenced the overall survival (OS) and build a fatty acid-related risk score (FARS) model. A nomogram was established based on the FARS and other clinicopathological features, and ROC and calibration plots were used to validate the prediction accuracy. The tumor microenvironment (TME) of patients with high and low FARS was compared.Results: A total of 38 genes were identified to be independently related to the survival outcome and put into a FARS model. High FARS patients exhibited significantly worse OS. The nomogram included the FARS and pathological stage, and the AUC of the nomogram predicting 1-, 2-, 3-, 4-, and 5-year OS was 0.789, 0.807, 0.798, 0.809, and 0.753, respectively. Calibration plots also indicated good accuracy. Moreover, the samples of the high FARS had higher expression of PDL1.Conclusion: We constructed a FARS model which could accurately predict the survival outcome of the LUAD patients. The genes of the FARS are related to the tumor microenvironment and patients with high FARS can potentially benefit more from anti-PD1/PDL1 immunotherapy. In addition, the mechanisms of the genes in the FARS affecting prognosis are worthy of further research to develop new gene-targeted drugs.https://www.frontiersin.org/articles/10.3389/fgene.2022.905508/fullfatty acid metabolismlung adenocarcinomaprognosisfatty acid-related risk scoreimmunotherapy |
| spellingShingle | Suyu Wang Suyu Wang Aona Chen Wanli Zhu Di Feng Juan Wei Quanfu Li Xuan Shi Xin Lv Meiyun Liu Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma Frontiers in Genetics fatty acid metabolism lung adenocarcinoma prognosis fatty acid-related risk score immunotherapy |
| title | Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma |
| title_full | Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma |
| title_fullStr | Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma |
| title_full_unstemmed | Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma |
| title_short | Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma |
| title_sort | characterization of fatty acid metabolism in lung adenocarcinoma |
| topic | fatty acid metabolism lung adenocarcinoma prognosis fatty acid-related risk score immunotherapy |
| url | https://www.frontiersin.org/articles/10.3389/fgene.2022.905508/full |
| work_keys_str_mv | AT suyuwang characterizationoffattyacidmetabolisminlungadenocarcinoma AT suyuwang characterizationoffattyacidmetabolisminlungadenocarcinoma AT aonachen characterizationoffattyacidmetabolisminlungadenocarcinoma AT wanlizhu characterizationoffattyacidmetabolisminlungadenocarcinoma AT difeng characterizationoffattyacidmetabolisminlungadenocarcinoma AT juanwei characterizationoffattyacidmetabolisminlungadenocarcinoma AT quanfuli characterizationoffattyacidmetabolisminlungadenocarcinoma AT xuanshi characterizationoffattyacidmetabolisminlungadenocarcinoma AT xinlv characterizationoffattyacidmetabolisminlungadenocarcinoma AT meiyunliu characterizationoffattyacidmetabolisminlungadenocarcinoma |